Clinical and biochemical evaluation of HIV-related lipodystrophy in an ambulatory population from the Hospital Universitário Cassiano Antonio de Morais, Vitória, ES, Brazil

by Bruno Zanotelli Monnerat, Crispim Cerutti Junior, Sheila Cristina Caniçali, Tânia Reuter Motta

The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study

by Paulo Roberto Abrão Ferreira, Mariliza Henrique da Silva, Carlos Eduardo Brandão-Melo, Rosamar Eulira Rezende, Mário Gonzalez, Tânia Reuter, Jose David Urbaez, Reinaldo Jose Gianini, Ana Martinelli, Maria Cássia Mendes-Correa
Published 2015-01-01

HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE

by Adauto CASTELO, Carlos Eduardo BRANDÃO MELLO, Rosangela TEIXEIRA, Jose Valdez Ramalho MADRUGA, Tania REUTER, Leila Maria Moreira Beltrão PEREIRA, Giovanni Faria SILVA, Mario Reis ÁLVARES-DA-SILVA, Heverton ZAMBRINI, Paulo Roberto Abrão FERREIRA

Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1–6 in Brazil

by Mario Peribañez-Gonzalez, Hugo Cheinquer, Lino Rodrigues, Maria Patelli Lima, Mário Reis Álvares-da-Silva, José Madruga, Edison Roberto Parise, Mário Guimarães Pessoa, Juvencio Furtado, Marcia Villanova, Adalgisa Ferreira, Felipe Mazzoleni, Ecio Nascimento, Giovanni Faria Silva, Linda Fredrick, Preethi Krishnan, Margaret Burroughs, Tania Reuter
Published 2021-01-01

Brazilian Society of Hepatology and Brazilian Society of Infectious Diseases Guidelines for the Diagnosis and Treatment of Hepatitis B

by Maria Lucia Ferraz, Edna Strauss, Renata Mello Perez, Leonardo Schiavon, Suzane Kioko Ono, Mario Pessoa Guimarães, Adalgisa Paiva Ferreira, Leticia Nabuco, Roberto Carvalho-Filho, Cristiane Tovo, Francisco Souto, Paulo Abrão, Tania Reuter, Thor Dantas, Aline Vigani, Gilda Porta, Marcelo Simão Ferreira, Raymundo Paraná, Sergio Cimerman, Paulo Lisboa Bittencourt
Published 2020-09-01

Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus

by Aline Vitali Grando, Paulo Roberto Abrão Ferreira, Mário Guimarães Pessôa, Daniel Ferraz de Campos Mazo, Carlos Eduardo Brandão-Mello, Tânia Reuter, Ana de Lourdes Candolo Martinelli, Mário Peribanez Gonzalez, Ana Catharina Seixas-Santos Nastri, Aléia Faustina Campos, Max Igor Banks Ferreira Lopes, José David Urbaez Brito, Maria Cássia Mendes-Corrêa
Published 2017-11-01

Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study

by Luciana Azevedo Callefi, Cristiane Alves Villela-Nogueira, Simone de Barros Tenore, Dimas Carnaúba-Júnior, Henrique Sérgio Moraes Coelho, Paulo de Tarso A. Pinto, Letícia Cancella Nabuco, Mário Guimarães Pessoa, Maria Lucia Cardoso Gomes Ferraz, Paulo Roberto Abrão Ferreira, Ana de Lourdes Candolo Martinelli, Silvana Gama Florencio Chachá, Adalgisa de Souza Paiva Ferreira, Alessandra Porto de Macedo Bisio, Carlos Eduardo Brandão-Mello, Mário Reis Álvares-Da-Silva, Tânia Reuter, Claudia Alexandra Pontes Ivantes, Renata de Mello Perez, Maria Cássia Jacintho Mendes-Correa